Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids
Ingrid Fricke‐Galindo,
Francisco M. Ortega‐Villafuerte,
Gloria Pérez‐Rubio,
Ivette Buendía‐Roldán,
Julián Ramírez‐Bello,
Azael A. Castillo Morales,
Leslie Chávez‐Galán,
Rafael de Jesús Hernández‐Zenteno,
Espiridión Ramos‐Martínez,
Salvador García‐Carmona,
Daniela Josefina Cataneo‐Piña,
Nora Edith Bautista‐Félix,
Ramcés Falfán‐Valencia Journal of Medical Virology
· Wiley
· 2026-10-30
· DOI: 10.1002/jmv.71201
Аннотация
Journal of Medical Virology, Volume 98, Issue 11, November 2026.
Ingrid Fricke‐Galindo, Francisco M. Ortega‐Villafuerte, Gloria Pérez‐Rubio, Ivette Buendía‐Roldán, Julián Ramírez‐Bello, Azael A. Castillo Morales et al. Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids. // Journal of Medical Virology. – 2026. – DOI: 10.1002/jmv.71201. – URL: https://onlinelibrary.wiley.com/doi/10.1002/jmv.71201?af=R
Ingrid Fricke‐Galindo, Francisco M. Ortega‐Villafuerte, Gloria Pérez‐Rubio, Ivette Buendía‐Roldán, Julián Ramírez‐Bello, Azael A. Castillo Morales, Leslie Chávez‐Galán, Rafael de Jesús Hernández‐Zenteno, Espiridión Ramos‐Martínez, Salvador García‐Carmona, Daniela Josefina Cataneo‐Piña, Nora Edith Bautista‐Félix, & Ramcés Falfán‐Valencia (2026). Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids. Journal of Medical Virology. https://doi.org/10.1002/jmv.71201
Ingrid Fricke‐Galindo, et al. “Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids.” Journal of Medical Virology, 2026. doi:10.1002/jmv.71201.
@article{FrickeGalindo2026,
title = {Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids},
author = {Fricke‐Galindo, Ingrid and Ortega‐Villafuerte, Francisco M. and Pérez‐Rubio, Gloria and Buendía‐Roldán, Ivette and Ramírez‐Bello, Julián and Morales, Azael A. Castillo and Chávez‐Galán, Leslie and Hernández‐Zenteno, Rafael de Jesús and Ramos‐Martínez, Espiridión and García‐Carmona, Salvador and Cataneo‐Piña, Daniela Josefina and Bautista‐Félix, Nora Edith and Falfán‐Valencia, Ramcés},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71201},
url = {https://onlinelibrary.wiley.com/doi/10.1002/jmv.71201?af=R}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...